Dry Eye Treatment | Envision by InMode
Our eyes are one of our most important tools, and eye health can be extremely important for our overall comfort, learning, and general cognition. However, more than 16.4 million Americans have been diagnosed with dry eye disease (DED), a condition that occurs when tears are insufficient to provide adequate lubrication for the eyes, and it has been estimated that up to half the population would say they suffer with some form of chronic dry eye.
The number of Americans that suffer with this condition is expected to worsen even more rapidly as we spend more and more time staring at screens. The blue light emitted by our computer screens, smart phones, and televisions causes further strain on our eyes, which can heighten our susceptibility to dye eye. Dry eye disease is often characterized by discomfort while blinking, red eyes, blurry vision, and a burning or itching sensation. The most common cause of DED is a condition known as meibomian gland dysfunction (MGD), in which the sebaceous glands around the eyes become clogged and unable to function correctly.
​
Despite the enormous number of people suffering with dry eye, there have been no truly effective solutions available to treat the condition, until now. In 2023, a new breakthrough technology for dry eye disease called Envision RF, by InMode, was released. This pioneering medical technology has been proven to treat the root cause of dry eye disease for effective, long-term results. Hartwater Aesthetics leads at the forefront of the industry, being the first practice in the world to offer the Envision RF modalities. Envision by InMode is set to be the future of dry eye treatments around the world. Schedule your consultation today so see if you qualify to be one of the very first in the nation to receive this groundbreaking treatment.
One of the Envision platform's key modalities is the Forma-I, a treatment which has been available internationally since 2022, but has been unavailable in the USA until now. Having now received a full clearance and indication from the FDA, Forma-I is now available for the first time in America at Hartwater Aesthetics. The Forma-I treatment addresses the root cause of dry eye by directly targeting the meibomian glands, which can be one of the leading causes of chronic dry eye.